Back to Search
Start Over
Let-7e sensitizes epithelial ovarian cancer to cisplatin through repressing DNA double strand break repair
- Source :
- Journal of Ovarian Research, Journal of Ovarian Research, Vol 10, Iss 1, Pp 1-13 (2017)
- Publication Year :
- 2017
- Publisher :
- BioMed Central, 2017.
-
Abstract
- Background Resistance to platinum-based chemotherapy remains a great challenge for ovarian cancer treatment. The human let-7 family contains 13 members located on nine different chromosomes, and most members have been implicated in the modulation of drug sensitivity in cancers. Our previous study showed that deregulation of let-7e in epithelial ovarian cancer (EOC) promoted the development of resistance to cisplatin. In the present study, we aimed to investigate the underlying mechanism and further evaluate the clinical value of let-7e in predicting chemo-response and prognosis in EOC. Results In situ hybridization assays revealed a significantly decreased expression of let-7e in chemo-resistant EOC tissues compared with chemo-sensitive cases. Transfection with let-7e agomir sensitized EOC cells to cisplatin, down-regulated BRCA1 and Rad51 expression, and repressed the repair of cisplatin-induced DNA double strand break, while let-7e inhibitor exerted the opposite effects. In human EOC tissues, BRCA1 and Rad51 levels were increased in the chemo-resistant group compared with the sensitive group and were negatively correlated with let-7e. Low let-7e and high Rad51 were significantly associated with poor progression-free survival and overall survival and multivariate regression analyses showed that let-7e was an independent predictor for overall survival and chemotherapy response in EOC. Receiver operating characteristic analysis indicated that let-7e level was highly predictive of resistance to platinum-taxane chemotherapy with an area under the curve of 0.826. Conclusions In EOC, low let-7e leads to activation of BRCA1 and Rad51 expression and subsequent enhancement of DSB repair, which in turn results in cisplatin-resistance. Let-7e is a potential predictor for survival and chemo-response in EOC and re-expression of let-7e might be an effective strategy for overcoming chemo-resistance. Electronic supplementary material The online version of this article (doi:10.1186/s13048-017-0321-8) contains supplementary material, which is available to authorized users.
- Subjects :
- 0301 basic medicine
Oncology
endocrine system diseases
DNA Repair
medicine.medical_treatment
RAD51
Carcinoma, Ovarian Epithelial
DSB
0302 clinical medicine
DNA Breaks, Double-Stranded
Neoplasms, Glandular and Epithelial
Ovarian Neoplasms
BRCA1 Protein
Let-7e
Obstetrics and Gynecology
Middle Aged
Prognosis
female genital diseases and pregnancy complications
Double Strand Break Repair
030220 oncology & carcinogenesis
Female
medicine.drug
Adult
medicine.medical_specialty
DNA repair
In situ hybridization
Biology
lcsh:Gynecology and obstetrics
03 medical and health sciences
Ovarian cancer
Internal medicine
Cell Line, Tumor
microRNA
medicine
Humans
lcsh:RG1-991
Aged
Cisplatin
Chemotherapy
Research
medicine.disease
BRCA1
MicroRNAs
030104 developmental biology
Drug Resistance, Neoplasm
Rad51
Rad51 Recombinase
Subjects
Details
- Language :
- English
- ISSN :
- 17572215
- Volume :
- 10
- Database :
- OpenAIRE
- Journal :
- Journal of Ovarian Research
- Accession number :
- edsair.doi.dedup.....0e1f8f74cbeba3a49304b0299315b4b8